低分子肝素联合阿魏酸钠治疗不稳定型心绞痛60例临床研究

目的研究低分子肝素联合阿魏酸钠治疗不稳定型冠心病心绞痛的疗效。方法将不稳定型冠心病心绞痛患者120例随机分为治疗组和对照组，对照组采取常规治疗的基础上加用复方丹参注射液和普通肝素，治疗组在常规治疗基础上加用低分子肝素和阿魏酸钠，服药14d后进行疗效评价。结果治疗组临床总有效率和心电图总有效率分别为93．33％和95．00％，明显高于对照组的80．00％和80．00％，两组比较差异有统计学意义（P〈0．05）。结论低分子肝素联用阿魏酸钠是治疗不稳定型心绞痛临床效果肯定且比较安全的方法。

Low Molecular Weight Heparin Combined with Sodium Ferulate in Treatment of Unstable Angina Pectoris: A Clinical Study

Objective To study the clinical effect of low molecular weight beparin（LMWH） combined with sodium ferulate on unstable angina pectoris. Methods All 120 cases of unstable angina pectoris were divided randomly into control group and treatment group. Besides the routine treatment, the control group received the compound injection of red sage root and common beparin, whereas the treatment group received LMWH combined with sodium ferulate,and the therapy effect after two-week treatment was evaluated. Results The total effective rate and the total effective rate of ECG in the treatment group were 93.33% and 95.00%,obviously higher than those of the control group（80.00% and 80.00%）,with a significant difference between the two groups（P〈0.05）, and the therapy effect of the treatment group was much better than that of the control group. Conclusion The therapy effect of LMWH combined with sodium ferulate on unstable angina peetoris is definite,with good clinical safety.